Clinical Study Circle of Willis Variants: Fetal PCA

Similar documents
Al Am een J Med Sci 2016; 9(2): US National Library of Medicine enlisted journal ISSN

Redgrave JN, Coutts SB, Schulz UG et al. Systematic review of associations between the presence of acute ischemic lesions on

Stroke/Carotid Artery Disease Outcome Detail (Form 121/132)

Stroke/Carotid Artery Disease Outcome Detail (Form 121/132, CaD ppts)

Research Article Abdominal Aortic Aneurysms and Coronary Artery Disease in a Small Country with High Cardiovascular Burden

Case Report Asymptomatic Pulmonary Vein Stenosis: Hemodynamic Adaptation and Successful Ablation

The Impact of Smoking on Acute Ischemic Stroke

UPDATES IN INTRACRANIAL INTERVENTION Jordan Taylor DO Metro Health Neurology 2015

Moyamoya Syndrome with contra lateral DACA aneurysm: First Case report with review of literature

Clinical Study Experiences of Thrombolytic Therapy for Ischemic Stroke in Tuzla Canton, Bosnia and Herzegovina

Case Report Tortuous Common Carotid Artery: A Report of Four Cases Observed in Cadaveric Dissections

Comparison of Five Major Recent Endovascular Treatment Trials

Research Article Predictions of the Length of Lumbar Puncture Needles

Multidetector computed tomographic (CT) angiography : FREQUENTLY ANATOMICAL VARIATIONS OF THE CIRCLE WILLIS ICONOGRAPHIC REVIEW

Research Article Identifying Prognostic Criteria for Survival after Resuscitation Assisted by Extracorporeal Membrane Oxygenation

[(PHY-3a) Initials of MD reviewing films] [(PHY-3b) Initials of 2 nd opinion MD]

Endovascular Treatment of Ischemic Stroke

Conference Paper Antithrombotic Therapy in Patients with Acute Coronary Syndromes: Biological Markers and Personalized Medicine

Management of intracranial atherosclerotic stenosis (ICAS)/intracranial atherosclerosis

Case Report Intracranial Capillary Hemangioma in the Posterior Fossa of an Adult Male

Case Report Anomalous Left Main Coronary Artery: Case Series of Different Courses and Literature Review


Clinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease

Assessment Of Collateral Pathways In Acute Ischemic Cerebrovascular Stroke Using A Mansour Grading Scale; A New Scale, A Pilot Study

Ischemic Stroke in Critically Ill Patients with Malignancy

Clinical Study Endovascular Recanalization for Chronic Symptomatic Intracranial Vertebral Artery Total Occlusion

Cryptogenic Strokes: Evaluation and Management

Emergency Department Stroke Registry Process of Care Indicator Specifications (July 1, 2011 June 30, 2012 Dates of Service)

collaterals offset ischemia

Basilar artery stenosis with bilateral cerebellar strokes on coumadin

ACUTE STROKE TREATMENT IN LARGE NIHSS PATIENTS. Justin Nolte, MD Assistant Profession Marshall University School of Medicine

Advances in Neuro-Endovascular Care for Acute Stroke

Supplementary Online Content

Research Article Opioid Use Is Not Associated with Incomplete Wireless Capsule Endoscopy for Inpatient or Outpatient Procedures

Significant Relationships

framework for flow Objectives Acute Stroke Treatment Collaterals in Acute Ischemic Stroke framework & basis for flow

Case Report Preoperative Assessment of Anomalous Right Coronary Artery Arising from the Main Pulmonary Artery

Research Article Relationship between Pain and Medial Meniscal Extrusion in Knee Osteoarthritis

Latest Advances in the Neurointerventional Treatment of Ischemic Stroke P A C I F I C N E U R O. O R G

The DAWN of a New Era for Wake-up Stroke

Mechanical thrombectomy beyond the 6 hours. Mahmoud Rayes, MD Medical Director, Stroke program Greenville Memorial Hospital

Canadian Best Practice Recommendations for Stroke Care. (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management

2/7/

COMPREHENSIVE SUMMARY OF INSTOR REPORTS

Advances in the treatment of posterior cerebral circulation symptomatic disease

Int J Clin Exp Med 2018;11(6): /ISSN: /IJCEM

Speakers. 2015, American Heart Association 1

Practical Considerations in the Early Treatment of Acute Stroke

Session : Why do stroke patients need a cardiologist? PREVALENCE OF CORONARY ATHEROSCLEROSIS IN PATIENTS WITH CEREBRAL INFARCTION

Clinical Study Copeptin: Limited Usefulness in Early Stroke Differentiation?

Carotid Endarterectomy for Symptomatic Complete Occlusion of the Internal Carotid Artery

Patient characteristics. Intervention Comparison Length of followup. Outcome measures. Number of patients. Evidence level.

Nicolas Bianchi M.D. May 15th, 2012

Deborah K. Mann & Jennifer Bash. Coding Documentation and Education Managers

Essentials of Clinical MR, 2 nd edition. 14. Ischemia and Infarction II

Vivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine

Recanalization of Chronic Carotid Artery Occlusion Objective Improvement Of Cerebral Perfusion

Chapter. Quantitative assessment of white matter lesions in patients with a bilateral fetal variant of the circle of Willis.

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

Early Neurologic Deterioration after Stroke Depends on Vascular Territory and Stroke Etiology

In cerebral infarction, the prognostic value of angiographic

Original Paper. Cerebrovasc Dis 2009;27: DOI: /

Acute Ischemic Stroke Imaging. Ronald L. Wolf, MD, PhD Associate Professor of Radiology

Perils of Mechanical Thrombectomy in Acute Asymptomatic Large Vessel Occlusion

IMAGING IN ACUTE ISCHEMIC STROKE

HAAD quality KPI; waiting time

ACUTE ISCHEMIC STROKE. Current Treatment Approaches for Acute Ischemic Stroke

Department of Internal Medicine, Saitama Citizens Medical Center, Saitama , Japan

Direction of Flow in Posterior Communicating Artery on Magnetic Resonance Angiography in Patients With Occipital Lobe Infarcts

Vertebrobasilar Insufficiency

Extra- and intracranial tandem occlusions in the anterior circulation - clinical outcome of endovascular treatment in acute major stroke.

Tom Eisele, Benedikt M. Muenz, and Grigorios Korosoglou. Department of Cardiology & Vascular Medicine, GRN Hospital Weinheim, Weinheim, Germany

Case Report Computed Tomography Angiography Successfully Used to Diagnose Postoperative Systemic-Pulmonary Artery Shunt Narrowing

Devendra V. Kulkarni, Rahul G. Hegde, Ankit Balani, and Anagha R. Joshi. 2. Case Report. 1. Introduction

Case Report Coronary Artery Perforation and Regrowth of a Side Branch Occluded by a Polytetrafluoroethylene-Covered Stent Implantation

Evaluation of Carotid Vessels and Vertebral Artery in Stroke Patients with Color Doppler Ultrasound and MR Angiography

Stroke Update. Lacunar 19% Thromboembolic 6% SAH 13% ICH 13% Unknown 32% Hemorrhagic 26% Ischemic 71% Other 3% Cardioembolic 14%

Case Report Successful Implantation of a Coronary Stent Graft in a Peripheral Vessel

Case Report A Rare Case of Near Complete Regression of a Large Cervical Disc Herniation without Any Intervention Demonstrated on MRI

Further Pragmatic Trials of Thrombectomy are Needed

Research Article Challenges in Assessing Outcomes among Infants of Pregnant HIV-Positive Women Receiving ART in Uganda

Case Report Crossed Renal Ectopia without Fusion An Unusual Cause of Acute Abdominal Pain: A Case Report

Case Report A Rare Case of Traumatic Bilateral Fibular Head Fractures

Clinical Study Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at a Tertiary Medical Center

CT and MR Imaging in Young Stroke Patients

TIA triage in Not all that glitters is gold

12/4/2017. Disclosures. Study organization. Stryker Medtronic Penumbra Viz Route 92. Data safety monitoring board Tudor G.

Clinical Study Cardioembolic but Not Other Stroke Subtypes Predict Mortality Independent of Stroke Severity at Presentation

Spontaneous Recanalization after Complete Occlusion of the Common Carotid Artery with Subsequent Embolic Ischemic Stroke

Case Report Ocular Symptomatology, Management, and Clinical Outcome of a Giant Intracranial Aneurysm

Is there even a time window?

Case Report Successful Mechanical Thrombectomy of a Middle Cerebral Artery Occlusion 14 Hours after Stroke Onset

Intracranial Atherosclerosis in Asians

DESCRIPTION: Percent of asymptomatic patients undergoing CEA who are discharged to home no later than post-operative day #2

Thrombectomy with the preset stent-retriever. Insights from the ARTESp* trial

Carotid Artery Revascularization: Current Strategies. Shonda Banegas, D.O. Vascular Surgery Carondelet Heart and Vascular Institute September 6, 2014

Stroke Clinical Trials Update Transitioning to an Anatomic Diagnosis in Ischemic Stroke

Clinical Study The Value of Programmable Shunt Valves for the Management of Subdural Collections in Patients with Hydrocephalus

Stroke is the third-leading cause of death and a major

Transcription:

Stroke Research and Treatment Volume 2013, Article ID 105937, 6 pages http://dx.doi.org/10.1155/2013/105937 Clinical Study Circle of Willis Variants: Fetal PCA Amir Shaban, 1 Karen C. Albright, 2,3,4,5 Amelia K. Boehme, 2,3 and Sheryl Martin-Schild 1 1 Stroke Program, Department of Neurology, Tulane University Hospital, 1440 Canal Street, TB-52, Suite 1000, New Orleans, LA 70112-2715, USA 2 Health Services and Outcomes Research Center for Outcome and Effectiveness Research and Education (COERE), University of Alabama at Birmingham, RWUH M226, 619 19th Street S, Birmingham, AL 35249-3280, USA 3 Center of Excellence in Comparative Effectiveness Research for Eliminating Disparities (CERED) Minority Health & Health Disparities Research Center (MHRC), University of Alabama at Birmingham, RWUH M226, 619 19th Street S, Birmingham, AL 35249-3280, USA 4 Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, AL 35294, USA 5 Department of Neurology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA Correspondence should be addressed to Amir Shaban; awshaban@gmail.com Received 14 November 2012; Revised 16 January 2013; Accepted 16 January 2013 Academic Editor: David S. Liebeskind Copyright 2013 Amir Shaban et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. We sought to determine the prevalence of fetal posterior cerebral artery (fpca) and if fpca was associated with specific stroke etiology and vessel territory affected. This paper is a retrospective review of prospectively identified patients with acute ischemic stroke from July 2008 to December 2010. We defined complete fpca as absence of a P1 segment linking the basilar with the PCA and partialfpcaas smallsegment linking the basilar withthe PCA.Patients without intracranial vascular imaging were excluded. We compared patients with complete fpca, partial fpca, and without fpca in terms of demographics, stroke severity, distribution, and etiology and factored in whether the stroke was ipsilateral to the fpca. Of the 536 included patients, 9.5% (n =51) had complete fpca and 15.1% (n=81) had partial fpca. Patients with complete fpca were older and more often female than partial fpca and no fpca patients, and significant variation in TOAST classification was detected across groups (P =0.023).Patients with complete fpcahadlesssmallvesselandmorelargevesselstrokesthanpatientswithnofpcaandpartialfpca.fetalpcamaypredispose to stroke mechanism, but is not associated with vascular distribution, stroke severity, or early outcome. 1. Introduction Fetal PCA (fpca) is a common variant of cerebral circulation. Two definitions of fpca exist in the literature: complete fetal PCA and partial fetal PCA. Complete fetal PCA (cfpca) is defined as posterior cerebral artery that completely originates from the internal carotid artery ICA with no connection with the basilar artery. Partial fetal PCA (pfpca) is defined as posterior cerebral artery originating from ICA with a small, or atretic, connection with the basilar. Available studies have largely used the pfpca definition. Variable prevalence of fpca has been demonstrated in healthy subjects (15 32%) and those with cerebral infarction (5 36%) using autopsy or magnetic resonance angiography (MRA). Unilateral pfpca is more frequent (11 29%) than bilateral pfpca (1 9%). Unilateral cfpca was detected in 4 26% of cases with only 2 4% having bilateral cfpca. Prevalence was lower with MRA than autopsy [1]. Study population (healthy subjects versus cerebral infarction) did not influence the fpca prevalence [1]. cfpca can impact the anatomy of the cerebral circulation. More area is perfused by the anterior circulation as PCA is completely supplied by ICA. In addition, leptomeningeal collaterals fail to develop between the ICA and the vertebrobasilar system since both the MCA and the PCA are connected to the internal carotid system and are above the physical barrier of the tentorium while the rest of the vertebrobasilar system is below the tentorium [1, 2]. pfpca has less impact on the vascular anatomy of the cerebral circulation: more area is perfused by the anterior circulation as PCA is

2 Stroke Research and Treatment (a) (b) (c) Figure 1: MRI TOF demonstrating a complete fetal PCA (cfpca) and partial fetal PCA (pfpca). (a) Typical pattern of PCAs as terminus of basilar artery. (b) Partial fpca on the right side. The arrow shows an atretic communication between the basilar artery and the posterior communicating artery forming the PCA. (c) Complete fpca on the left side. The arrow shows lack of communication between the basilar artery and the PCA. mostly supplied by ICA, but the leptomeningeal collaterals may develop between anterior and posterior circulation due to the small connection that PCA has with the basilar. Important potential consequences of this fetal variant of the circle of Willis have been demonstrated, but studies are conflicting. Increased stroke burden has been described in postmortem studies of patients with fpca [1, 3, 4]. Another study involving living humans (n =82), however, failed to demonstrate increased risk for cerebral ischemia in patients with fpca [5]. fpca results in left-right asymmetry on perfusion imaging which could contribute to misdiagnosis of an ischemic event, but the clinic importance of this asymmetry is yet to be determined [6]. No large study suggested that presence of fpca may increase the likelihood of large artery stroke. However, a small exploratory study of only 18 patients with small vertebrobasilar system and fpca described the distribution of stroke etiology with the majority of patients having large artery disease (66.7%, n=12) and smaller proportions having small artery occlusions (16.7%, n = 3), cardioembolic (5.6%, n = 1), and undetermined etiology (11.1%, n=2)[7]. Studies of this nature are limited and often small in sample size. Despite fpca being a common variant, very little is known about how this variant impacts ischemic stroke characteristics. The aim of this study was to determine if the presence of fpca influences stroke outcome, location, severity, and etiology. 2. Materials and Methods 2.1. Patients. A retrospective analysis of prospectively identified consecutive patients who presented to our medical center withacuteischemicstrokebetweenjuly2008anddecember 2010 was conducted. Patients without cerebrovascular imaging (magnetic resonance angiography (MRA) or computed tomographic angiography (CTA)) were excluded from this study. 2.2. Definitions. We defined fpca as cfpca when posterior cerebral artery completely originates from the internal carotid artery ICA with no connection with the basilar artery and pfpca when posterior cerebral artery originates fromicawithasmallatreticconnectionwiththebasilar [1] (Figure 1). Patients who had cfpca on one side and pfpca on the other were considered as cfpca patients. We defined another two groups of patients: patients with cfpca on the same side of the stroke (ipsilateral cfpca) and patientswithpfpcaonthesamesideofthestroke(ipsilateral pfpca). Patients with bilateral strokes were excluded from this subgroup analysis. Stroke etiology was categorized using TOAST classification [8]. 2.3. Scans. CTAandMRAscanswereinterpretedbyatrained stroke research fellow (AS) and reviewed for confirmation of correct assignment by a board certified vascular neurologist (SMS). 2.4. Statistics. Categorical data are presented as frequencies andwerecomparedusingthepearsonchi-squaredorfisher exact test where appropriate. Continuous data are presented as medians with ranges and were compared using Wilcoxon Rank Sum test. All tests were performed at the α = 0.05 level and were two sided. We compared admission demographics, initial stroke severity as measured by the baseline NIHSS, vascular distribution of infarction, and TOAST classification in patients with cfpca, pfpca, and no fpca (normal cerebral circulation). Patients with cfpca ipsilateral to their stroke were compared to patients with pfpca ipsilateral to their

Stroke Research and Treatment 3 Table 1: Demographics, vascular risk factors, and outcome in patients without fetal PCA (no fpca), partial fetal PCA (pfpca), and complete fetal PCA (cfpca). No fpca pfpca cfpca n = 405 n = 81 n = 51 Age, median years (min max) IQR 62 (19 97) 52, 74 63 (26 93) 55, 72 74 (28 90) 57, 79 0.025 Gender, no. (female) (%) 163/405 (40.2%) 30/81 (37.0%) 31/51 (60.8%) 0.013 Race, no. (%) 0.362 White 131/403 (32.5%) 25/81 (30.9%) 8/48 (16.7%) Black 257/403 (63.8%) 52/81 (64.2%) 40/48 (83.3%) Hispanic 10/403 (2.5%) 2/81 (2.5%) 0/48 (0%) Other 2/403 (0.5%) 1/81 (1.2%) 0/48 (0%) History of prior stroke 167/402 (41.5%) 31/81 (38.3%) 22/51 (43.1%) 0.825 History of hypertension 293/399 (73.4%) 63/79 (79.7%) 39/51 (76.5%) 0.476 History of diabetes 127/400 (31.8%) 28/80 (35.0%) 13/51 (25.5%) 0.519 History of hyperlipidemia 164/398 (41.2%) 31/78 (39.7%) 25/51 (49.0%) 0.526 Active smoker 139/394 (35.3%) 30/80 (37.5%) 10/51 (19.6%) 0.066 Admission NIHSS, median (min max) IQR 5 (0 36) 3, 12 5 (0 31) 3, 10 7 (0 27) 3, 14 0.630 Discharge NIHSS, median (min max) IQR 2 (0 42) 1, 7 3 (0 42) 1, 9 2 (0 42) 1, 9 0.586 Discharge mrs, median (min max) IQR 3 (0 6) 1, 4 3 (0 6) 2, 4 3 (0 6) 1.5, 4 TOAST, no. (%) 0.023 Cardioembolic, no. (%) 97/404 (24.0%) 19/80 (23.8%) 9/50 (18.0%) Large vessel, no. (%) 97/404 (24.0%) 25/80 (31.3%) 20/50 (40.0%) Small vessel, no. (%) 88/404 (21.8%) 19/80 (23.8%) 6/50 (12.0%) Crypto (>1 etiology), no. (%) 8/404 (2.0%) 1/80 (1.3%) 4/50 (8.0%) Crypto (unknown), no. (%) 70/404 (17.3%) 9/80 (11.3) 10/50 (50.0%) Other, no. (%) 44/404 (10.9%) 7/80 (8.8%) 1/50 (2.0%) stroke and to patients with fpca without an accompanying ipsilateral stroke. As this was an exploratory analysis, no adjustments were made for multiple comparisons [9]. The retrospective chart review was approved by the institutional review board at the Tulane University (IRB protocol number 297713-1). 3. Results 3.1. Demographics. Of the 596 patients who presented to our center, 536 patients met the inclusion criteria. The median age was 62 years old, with 41.7% (224/537) females and 65.6% (286/532) blacks. MRA was performed in 502 patients and 183 had CTA. Of the patients with complete data, 133 had bothmraandctaperformed.mrawasabletocorrectly identify 10 of the 11 complete fetal PCAs that were detected using CTA and correctly rule out complete fetal PCA in 121 of the 122 ruled out by CTA. Using CTA as the gold standard, the sensitivity of MRA for detecting complete fetal PCA in our sample was 90.9% (95% CI 64.4 99.2%) while specificity was 99.2% (95% CI 96.8 99.9%). In our sample, partial fpcas 15.1% (81/536) were more common than complete fpcas 9.5% (51/536). Of complete fpcas, 45.1% (23) were on the right side, 35.3% (18) were on the left side, and 19.6% (10) were bilateral. Of partial fpcas, 43.9% (36) were on the right side, 23.3% (19) were on the left side, and 32.9% (27) were bilateral. An additional 8 patients had cfpca on one side and pfpca on the other. After excluding patients who experienced bilateral stroke or had evidence bilateral complete fetal PCA, we found that 38.7% (12/31) of patients with evidence of complete fetal PCA had ipsilateral stroke (not significantly different from 50.0%, P= 0.374). Baseline demographic information, atherosclerotic risk factors, and NIHSS at baseline were compared among patients with no fpca, pfpca, and cfpca (Table 1). Patients with complete fpca were older (P = 0.025) and more commonly female (P = 0.013) whencomparedto patients with partial or no fpca. The prevalence of vascular risk factors was similar among groups. The median NIHSS at the admission was higher for complete fpca patients (7; range, 0 27) when compared to partial fpca (5; range, 0 31) or no fpca (5; range, 0 36). 3.2. Stroke Etiology (TOAST). There was a significant difference among groups of the patients (P = 0.023). Nearly half of patients with cfpca had large vessel etiology (40.0%, 20/50) compared to less than one-third of pfpca patients (31.3%, 25/80), and less than one-fourth of patients with no fpca (24%, 97/404). Patients with cfpca had the lowest proportion of small vessel etiology (12%, 6/50) compared to pfpca and no fpca patients (23.8%, 19/80; 21.8%, 88/404). These results are detailed in Table 1. After excluding patients with an acute stroke contralateral to an fpca and those with bilateral strokes, etiology and vascular distribution of stroke were compared in patients with stroke ipsilateral to cfpca, patients with stroke ipsilateral to

4 Stroke Research and Treatment Table2:TOASTclassificationandvesselinvolvementinpatientswithoutfetalPCA(nofPCA),partialfetalPCAwithipsilateralstroke (ipsilateral pfpca), and complete fetal PCA with ipsilateral stroke (ipsilateral cfpca). No fpca Ipsilateral pfpca Ipsilateral cfpca N=356 N=46 N=20 TOAST, no. (%) 0.621 Cardioembolic, no. (%) 73 (20.5%) 10 (21.7%) 2 (10.0%) Large vessel, no. (%) 102 (28.7%) 14 (30.4%) 10 (50%) Small vessel, no. (%) 87 (24.4%) 10 (21.7%) 3 (15.0%) Crypto (>1 etiology), no. (%) 7 (2.0%) 1 (2.2%) 1 (5.0%) Crypto (unknown), no. (%) 53 (14.9%) 6 (13.0%) 4 (20.0%) Other, no. (%) 34 (9.6%) 5 (10.9%) 0 (0%) MCA involved in the stroke 262/351 (74.6%) 38/46 (82.6%) 15/20 (75.0%) 0.497 PCA involved in the stroke 36/351 (10.3%) 3/46 (6.5%) 4/20 (20.0%) 0.253 Posterior circulation involvement 45/351 (12.8%) 7/46 (15.2%) 5/20 (25.0%) 0.289 Table 3: Vascular involvement of the stroke in patients without fetal PCA (no fpca), partial fetal PCA (pfpca), and complete fetal PCA (cfpca). No fpca pfpca cfpca N = 387 n = 78 n = 48 MCA involved in the stroke 269 (69.5%) 52 (66.7%) 36 (75.0%) 0.613 PCA involved in the stroke 54 (14.0%) 7 (9.0%) 8 (16.7%) 0.396 Posterior circulation involvement 68 (17.6%) 16 (20.5%) 11 (22.9%) 0.591 pfpca,andpatientswithstrokethatwasnotipsilateralto either cfpca nor pfpca (Table 2). Patients with ipsilateral cfpca had higher frequency of large vessel disease (50%, 10/20), compared to 30.4% (14/46) of patients with ipsilateral pfpca and 28.7% (102/356) of patients with no fpca. There was no difference in the proportion of strokes that were ipsilateral to a cfpca (59.0%) compared to those with stroke ipsilateral to pfpca (66.2%). Furthermore, there was no difference in the ratio of right : left sided strokes comparing patients with cfpca (1.3 : 1) with patients with pfpca (1.3 : 1). Interestingly, in one of our subgroup analyses we excluded all cases of no fpca, cases of bilateral cfpca or pfpca, cases of cfpca on one side and pfpca on the other, cases with no stroke on MRI; and cases with bilateral stroke on MRI, we end up with 70 cases, those who have cfpca (n = 24) or pfpca (n =46) on a single side and detectable stroke on a single side. Strokes were ipsilateral to complete fpca in 10/24 (41.7%) cases and ipsilateral to partial fpca in 23/46 (50%) cases. 3.3. Vessel Involved. The vascular distribution of the stroke was determined in 95.7% (513/536) of patients. We found no significant difference in the involvement of MCA, PCA, or the posterior circulation comparing the no fpca, pfpca, and cfpca groups of patients (Table 3). 3.4. Stroke Outcome. No differences were detected in any of our outcome variables including occurrence of neurological deterioration, symptomatic intracranial hemorrhage, length of stay, death, discharge modified Rankin Scale score, or discharge disposition when comparing no fpca, pfpca, and cfpca, or when comparing ipsilateral cfpca, pfpca, and no fpca (Table 4). 4. Comment DespitefPCAbeingacommonvariant,verylittleisknown about the prevalence and relevance of fpca among patients with stroke. The prevalence in our population was similar to studies involving healthy subjects [1], rendering fpca an unlikely candidate for a significant risk factor for ischemic stroke. We did find imbalances in patient characteristics among thosewithstrokeandfpca.patientswithcompletefpca were older. Since fetal PCA is a congenital variant, it could therefore be argued that a complete fpca is protective. Similar frequencies of a prior history of stroke in patients with complete fpca and those without fpca argue against this. Patients with complete fpca were more likely to be female. We found no published study providing evidence for increased frequency of complete fpca in women in the general population. It is possible that women with complete fpcaaremoresusceptibletostroke,butthemechanismfor such risk is unknown. We found no differences in baseline characteristics comparing patients without fpca and those with partial fpca. We found a difference in the distribution of stroke etiology comparing patients with and without fpca. Patients with cfpca had different distribution of TOAST classification from other patients. The higher frequency of large vessel etiology and lower frequency of small vessel etiology are in keeping with the influence of lack of thalamoperforators in the absence of a P1 segment connecting the PCA with the basilar

Stroke Research and Treatment 5 Table 4: Demographics, vascular risk factors, and outcome in patients without fetal PCA (no fpca), ipsilateral partial fetal PCA (pfpca), and ipsilateral complete fetal PCA (cfpca). No fpca ipsilateral to stroke Ipsilateral pfpca Ipsilateral cfpca n=356 N=47 N=20 Age, mean (SD) 62.6 (14.7) 63.5 (13.2) 72.8 (12.5) 0.014 Female, % 38.9 44.7 55.0 0.294 Race, % 0.568 White 29.1 (103/354) 27.7 (13/47) 20 (4/20) Black 67.2 (238/354) 68.1 (32/47) 80 (16/20) Hispanic 2.5 (9/354) 0 0 Other 0.3 (1/354) 2.1 (1/47) 0 Admission glucose, mean (SD) 139.2 (75.6) 148.5 (98.3) 135.4 (47.6) 0.611 Baseline NIHSS, median (min max) 5 (0 36) 7 (0 24) 5 (0 26) 0.969 Discharge NIHSS, median (min max) 3 (0 42) 4 (0 42) 3 (0 42) 0.678 Discharge mrs, median (min max) 3 (0 6) 3 (0 6) 3.5 (0 6) Discharge mrs 0 2, % 40.8 40.9 25.0 0.373 Discharge disposition 0.891 Home 165/353 (46.7%) 23/46 (50.0%) 9/20 (45.0%) Long term acute care 12/353 (3.4%) 3/46 (6.5%) 1/20 (5.0%) Inpatient rehab 119/353 (33.7%) 17/46 (37.0%) 6/20 (30.0%) Hospice 10/353 (2.8%) 0/46 (0%) 0/20 (0%) Skilled nursing 22/353 (6.2%) 2/46 (4.3%) 2/20 (10%) Dead 21/353 (5.9%) 1/46 (2.2%) 2/20 (10%) Other 4/353 (1.1%) 0/46 (0%) 0/20 (0%) Length of stay, median (min max) 5.5 (1 52) 6 (1 49) 6.5 (1 44) 0.848 artery. We did not, however, find a higher frequency of small vessel etiology among patients with pfpca. We expected that a small P1 segment would permit development of small thalamoperforators that would be vulnerable to atherosclerotic failure. While we found higher frequency of female patients among those with cfpca and females may be more likely to have a small vessel disease than men [10], patients with cfpca had lower frequency of small vessel disease. We detected no clinical influence of the presence of fetal PCA on the outcome ischemic stroke patients. Our study expectations were based on previous literature describing the paucity of leptomeningeal collateral flow between anterior and posterior circulation, the association of the collaterals with less ischemic stroke among patients with ICA disease [11], and also the association between leptomeningeal collateralsseenonctaandgoodoutcomeafterischemicstroke [12]. We sought to determine the frequency and implication of stroke ipsilateral to fpca. In the presence of fpca, we expected to find a disproportionate number of strokes ipsilateral to the fpca. The likelihood of a stroke being ipsilateral versus contralateral to an fpca, however, was not greater than the flip of a coin, further suggesting that the presence of fpca does not increase the risk of ischemic stroke. Furthermore, we were unable to detect significant difference in the distribution of vascular involvement and any stroke outcome comparing patients with no fpca, pfpca, and cfpca, though our sample size may have limited our power to detect such a difference. Our results represent the largest series of patients with ischemic stroke examined for the presence and relevance of fetal PCA in patients with acute ischemic stroke. Among patients with acute ischemic stroke, the frequency of pfpca (about 15%) and cfpca (about 10%) was not higher than that in prior reports of persons in the general population. Similar prevalence suggests that the presence of an fpca is notasignificantriskfactorforthedevelopmentofischemic stroke. Furthermore, the presence of pfpca or cfpca had no association with side of infarction or early clinical outcomes after infarction. We found no evidence that partial fetal PCA patients differ from patients with normal P1 segments in terms of demographics, stroke severity, etiology, and outcomes. The presence of a cfpca, however, was associated with an increased frequency of large vessel etiology. Our studywaslimitedbyitsretrospectivenatureandthesmall number of patients with stroke ipsilateral to the side of stroke to compare the distribution of vascular involvement and stroke outcomes. We acknowledge that difference on TOAST classification, age, and gender may be due to chance; a larger study needed to confirm our findings. Future studies should focusonstrokeinpatientswithcompletefetalpca. References [1] A. F. van Raamt, W. P. Mali, P. J. van Laar, and Y. van der Graaf, The fetal variant of the circle of Willis and its influence on the cerebral collateral circulation, Cerebrovascular Diseases,vol.22, no. 4, pp. 217 224, 2006.

6 Stroke Research and Treatment [2] D. S. Liebeskind, Collateral circulation, Stroke, vol.34,pp. 2279 2284, 2003. [3] M. Kameyama and S. H. Okinaka, Collateral circulation of the brain with special reference to atherosclerosis of the major cervial and cerebral arteries, Neurology, vol. 13, pp. 279 286, 1963. [4]S.K.Battacharji,E.C.Hutchinson,andA.J.Mccall, The circle of willis the incidence of developmental abnormalities in normal and infarcted brains, Brain, vol. 90, no. 4, pp. 747 758, 1967. [5] C. de Monyé, D. W. J. Dippel, T. A. M. Siepman, M. L. Dijkshoorn,H.L.J.Tanghe,andA.vanderLugt, Isafetal origin of the posterior cerebral artery a risk factor for TIA or ischemic stroke? A study with 16-multidetector-row CT angiography, JournalofNeurology,vol.255,no. 2,pp.239 245, 2008. [6]A.L.Wentland,H.A.Rowley,K.K.Vigen,andA.S.Field, Fetal origin of the posterior cerebral artery produces leftright asymmetry on perfusion imaging, American Neuroradiology,vol.31,no.3,pp.448 453,2010. [7] J. H. Park, J. K. Roh, and H. M. Kwon, Ischemic stroke patterns and hemodynamic features in patients with small vertebrobasilar artery, the Neurological Sciences,vol. 287,no.1-2,pp.227 235,2009. [8] H.P.Adams,B.H.Bendixen,L.J.Kappelleetal., Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial, Stroke,vol.24,no.1,pp.35 41,1993. [9] R. Bender and S. Lange, Adjusting for multiple testing when and how? Clinical Epidemiology, vol. 54, no. 4, pp. 343 349, 2001. [10] F. Palm, C. Urbanek, J. Wolf, F. Buggle, T. Kleemann, M. G. Hennerici et al., Etiology, risk factors and sex differences in ischemic stroke in the Ludwigshafen Stroke Study, a populationbased stroke registry, Cerebrovascular Diseases,vol.33,pp.69 75, 2012. [11] R. D. Henderson, M. Eliasziw, A. J. Fox, P. M. Rothwell, and H. J. M. Barnett, Angiographically defined collateral circulation and risk of stroke in patients with severe carotid artery stenosis, Stroke,vol.31,no.1,pp.128 132,2000. [12]F.O.Lima,K.L.Furie,G.S.Silvaetal., Thepatternofleptomeningeal collaterals on ct angiography is a strong predictor of long-term functional outcome in stroke patients with large vessel intracranial occlusion, Stroke, vol. 41, no. 10, pp. 2316 2322, 2010.

MEDIATORS of INFLAMMATION The Scientific World Journal Gastroenterology Research and Practice Diabetes Research International Endocrinology Immunology Research Disease Markers Submit your manuscripts at BioMed Research International PPAR Research Obesity Ophthalmology Evidence-Based Complementary and Alternative Medicine Stem Cells International Oncology Parkinson s Disease Computational and Mathematical Methods in Medicine AIDS Behavioural Neurology Research and Treatment Oxidative Medicine and Cellular Longevity